4:22 PM ET
8-K
Other 8-K Filing
LeonaBio Other 8-K Filing
LeonaBio announced that Series A Common Warrants issued in a December 2025 private placement have become exercisable as of September 18, 2026. If the warrants are exercised in full for cash at the $6.35 exercise price, the company would receive approximately $146.2 million in additional capital. The warrants remain exercisable until October 19, 2026.
- Term
- through Oct 19, 2026